Given our current findings that ADAM17 plays an important role in regulating liver injury and sickness behavior development in BDL mice, we next delineated changes in hepatic ADAM17 expression in the setting of two important cholestatic liver diseases in patients; PBC and PSC. This evidence concerns the gene ADAM17 and primary biliary cholangitis.